Skip to content

Barry Ticho, Chief Medical Officer at Stoke Therapeutics, sold STOK on Aug 18, 2026

Data as of Oct 16

▼ SELL$145K4,525 shares at $32.01Barry Ticho Chief Medical OfficerSTOK Stoke Therapeutics, Inc.
Watch STOK
Traded
Aug 18, 2026
Disclosed
Aug 18, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Barry Ticho, Chief Medical Officer at Stoke Therapeutics, sold STOK on Aug 18, 2026TRADEDDISCLOSED
STOKSimilar stocks (XLV — its sector index fund), rebased to STOK's price on the disclosure day
STOK since disclosure
−24.8%
after the sale
Similar stocks (XLV) since disclosure
+4.1%
XLV — its sector index fund

Change in closing price from Aug 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLBarry Ticho Chief Medical OfficerSTOK Stoke Therapeutics, Inc.$7.9Kdisclosed Aug 18 · filed the same day

See every trade on STOK →